ProteoGenix

ProteoGenix is a science-driven biotechnology company providing antibody discovery, production, and bioproduction services for therapeutic, diagnostic, research, and animal health applications. Its end-to-end solutions span antigen design, antibody generation, characterization, optimization, and production, connecting AI-based design with laboratory validation. The company offers monoclonal, polyclonal, recombinant, VHH, and fully human antibody services, as well as antibody engineering for formats such as bispecifics and antibody-drug conjugates. High-throughput programs can express thousands of candidates in parallel, with a guaranteed 1 mg per antibody for testing; other production services cover milligram-to-gram quantities and larger-scale manufacturing.

ProteoGenix also provides protein expression across five systems, stable cell-line development, expression optimization, and protein characterization. Additional services include gene and peptide synthesis, peptide libraries and conjugation, epitope mapping, and antibody labeling. Its catalog features primary antibodies, recombinant proteins, ELISA assay kits, and cell-separation media. Proprietary platforms include AIxplore® for antibody design, RocketAbs™ for immunization, and XtenCHO™ Race for transient CHO expression. ProteoGenix also shares technical resources, case studies, and tools to support biologics development.